[ad_1] Major stock indexes ended mostly higher Wednesday, building on a long run of gains. The S&P 500 added 0.1%, notching an eighth-straight session in the green. The Nasdaq Composite…
Tag: BIIB
First Pill for Postpartum Depression Is Approved by FDA
[ad_1] The first pill to treat post-pregnancy depression will soon be available, after the Food and Drug Administration approved it. [ad_2] Source link
Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet
[ad_1] The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity. [ad_2] Source link
Alzheimer’s Blockbuster Is Coming, but Slowly
[ad_1] Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients. [ad_2] Source link
Medicare Plans to Cover Alzheimer’s Drugs
[ad_1] Biogen and Eisai’s Leqembi is up for full approval this summer. [ad_2] Source link
Eli Lilly Results Signal Arrival of Blockbuster New Drug Class
[ad_1] Share Listen (2 min) [ad_2] Source link
Biogen Boss Turns Corner on Alzheimer’s Miscues
[ad_1] The biotech company needs to embark on new growth path as former Sanofi CEO Chris Viehbacher takes the helm. [ad_2] Source link
FDA Seeks More Data on Lilly’s Alzheimer’s Drug Candidate
[ad_1] Business Health Care Health Setback could delay potential commercial introduction by at least several months [ad_2] Source link
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.
[ad_1] Pharmaceutical companies could try to blunt the limits on future price increases. [ad_2] Source link